Amoxicillin

Edina Avdic, Pharm.D.
Pediatric Dosing Author: Bethany Sharpless Chalk, Pharm.D., BCPPS

INDICATIONS

FDA

Treatment of infections due to susceptible (β-lactamase-negative) strains causing the following syndromes:

  • Infections of the ear, nose, and throat – due to Streptococcus spp. (α- and β-hemolytic strains), S. pneumoniae, Staphylococcus spp., or H. influenzae
  • Infections of the genitourinary tract – due to E. coli, P. mirabilis, or E. faecalis.
    • Note: empiric use is not recommended by IDSA due to higher rates of resistance to E. coli and poor efficacy[3].
  • Infections of the skin and skin structure – due to Streptococcus spp. (α- and β-hemolytic strains), Staphylococcus spp., or E. coli
  • Infections of the lower respiratory tract – due to Streptococcus spp. (α- and β-hemolytic strains), S. pneumoniae, Staphylococcus spp., or H. influenzae
  • Gonorrhea, acute uncomplicated (ano-genital and urethral infections) – due to N. gonorrhoeae (males and females). Note: amoxicillin is not recommended by the CDC for the treatment of gonorrhea due to high rates of resistance.
  • H. pylori eradication to reduce the risk of duodenal ulcer recurrence in combination with other agents.

Amoxicillin ER tablet (Mmoxtag™) is indicated for the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatric patients ≥12 y/o

NON-FDA APPROVED USES

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: June 6, 2020